Norman C. Selby - May 14, 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Role
Director
Signature
/s/ Norman Selby
Stock symbol
INFI
Transactions as of
May 14, 2021
Transactions value $
$4,600
Form type
4
Date filed
5/18/2021, 04:32 PM
Next filing
Jun 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INFI Common Stock Options Exercise $4.6K +5K +50% $0.92* 15K May 14, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Options Exercise $0 -5K -12.5% $0.00 35K May 14, 2021 Common Stock 5K $0.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 17, 2020, the Reporting Person was granted 40,000 stock options, 30,000 of which were eligible to vest as long as the holder continued to serve as a director of the issuer and 10,000 of which were eligible to vest as long as the holder continued to serve as Lead Independent Director of the issuer's Board of Directors. The stock options vested over a period of one year in equal quarterly installments beginning at the end of the first calendar quarter after the date of grant. All 40,000 stock options are currently exercisable.